Your session is about to expire
← Back to Search
Handgrip Test for Heart Function Assessment in Adults
N/A
Recruiting
Led By Satish R Raj, MD MSCI
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Clinical heart failure (HFrEF or HFpEF) for heart failure patients and no clinical heart failure for the non-heart failure participants.
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial will assess whether or not the "head capacity principle" can be used to assess left ventricular pump function in human adults, with or without heart failure.
Who is the study for?
This trial is for adults over 18 with heart failure, as well as those without it. Participants must be able to give informed consent and not be on IV medications like inotropes or pressors that help maintain heart function.Check my eligibility
What is being tested?
The study tests new non-invasive methods to assess systemic circulation and left ventricular performance using a handgrip test. It involves one outpatient visit where subjects perform the grip test while monitored with EKG electrodes and blood pressure cuffs.See study design
What are the potential side effects?
Since this trial uses non-invasive monitoring during a handgrip exercise, side effects are minimal but may include temporary discomfort from gripping or wearing the monitoring devices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have heart failure or I do not have heart failure, depending on the study group I am in.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Head-Capacity Curve (HCC)
Secondary outcome measures
Cardiac Power
Systemic Vascular Conductance (SVC)
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: HFrEFExperimental Treatment1 Intervention
patients with heart failure with reduced ejection fraction
Group II: HFpEFExperimental Treatment1 Intervention
heart failure with preserved ejection fraction
Group III: ControlActive Control1 Intervention
healthy (no heart failure) control participants
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,054 Total Patients Enrolled
13 Trials studying Heart Failure
6,286 Patients Enrolled for Heart Failure
Satish R Raj, MD MSCIPrincipal InvestigatorUniversity of Calgary
19 Previous Clinical Trials
1,326 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have heart failure or I do not have heart failure, depending on the study group I am in.I am on IV medication to support my heart function.I cannot or do not want to give permission for treatment.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: HFrEF
- Group 2: HFpEF
- Group 3: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the recruitment process for this experiment still ongoing?
"Clinicaltrials.gov attests to the fact this trial is actively recruiting patients, with its inception on September 15th 2021 and most recent edit taking place February 4th 2022."
Answered by AI
To what extent is enrollment progressing for this clinical trial?
"Affirmative. The clinicaltrials.gov entry for this experiment confirms active recruitment began on September 15th, 2021 and was most recently updated February 4th 2022. Participating sites need to recruit 100 patients in total."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger